New italian registry aims to unlock secrets of rare brain disease
NCT ID NCT06844877
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a registry of 50 people with NCL, a rare and severe brain disorder. Researchers will collect detailed clinical data, biomarkers, and patient-reported outcomes over time. The goal is to better understand the disease's natural history and develop tools that can be used in future treatment trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide the detailed data needed to design better clinical trials for NCL treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly improve symptoms or slow the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEURONAL CEROID LIPOFUSCINOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Fondazione Stella Maris
RECRUITINGPisa, 56128, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.